Navinci Diagnostics raised €8.5M in a Series A round in Jul 2022. The company is based in Uppsala, Sweden. Investors in the round: Beijer Ventures, Landegren Gene Technology, Nexttobe and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
